Article info

Download PDFPDF
Systematic review and meta-analysis
Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma

Authors

  1. Correspondence to: Professor Neil C Thomson, Institute of Infection, Immunity & Inflammation, University of Glasgow and Respiratory Medicine, Gartnavel General Hospital, Glasgow, G12 OYN, UK; neil.thomson{at}glasgow.ac.uk
View Full Text

Citation

Thomson NC
Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma

Publication history

  • First published March 13, 2014.
Online issue publication 
July 18, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.